These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5822128)

  • 1. [Study of the pharmacology of quipazine maleate. II. Effects of quipazine maleate on the central nervous system].
    Guzmán-Flores C; Alcaraz M
    Gac Med Mex; 1969 Aug; 99(8):747-57. PubMed ID: 5822128
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the pharmacology of the quipazine maleate. I. General pharmacology of quipazine maleate].
    Hong E; Phillips BM; Pardo EG
    Gac Med Mex; 1969 Aug; 99(8):741-6. PubMed ID: 5387704
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the pharmacology of quipazine maleate. 3. Possible analogies between serotonin and quipazine maleate].
    Pardo EG; Hong E; Sancillo LF; Vargas R
    Gac Med Mex; 1969 Aug; 99(8):758-64. PubMed ID: 5822129
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin-like actions of quipazine on the central nervous system.
    Rodríguez R; Rojas-Ramírez JA; Drucker-Colín RR
    Eur J Pharmacol; 1973 Nov; 24(2):164-71. PubMed ID: 4543615
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the pharmacology of quipazine maleate. IV. Final comments].
    Vargas R
    Gac Med Mex; 1969 Aug; 99(8):764-5. PubMed ID: 5822130
    [No Abstract]   [Full Text] [Related]  

  • 6. Some behavioral effects induced by quipazine administration in the cat.
    Guzmán-Flores C; Pacheco P; Hong E; Pardo EG
    Bol Estud Med Biol; 1970 Apr; 26(6):225-32. PubMed ID: 5514964
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of ether inhalation on the central nervous system activities of the cat].
    Mori K; Mitani Z; Fujita M
    Masui; 1970 Apr; 19(4):341-9. PubMed ID: 5464946
    [No Abstract]   [Full Text] [Related]  

  • 8. [Introduction to a metabolic pharmacology and electrogenesis of the central nervous system. Experimental study].
    Laborit H; Baron C; Weber B
    Agressologie; 1965; 6(6):655-720. PubMed ID: 5854524
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological studies on monosodium homocystate. 3. Effects of monosodium homocystate on the central nervous system and general metabolism].
    Yakazu K
    Zasshi Tokyo Ika Daigaku; 1966 Mar; 24(1):67-88. PubMed ID: 4962870
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of neurohypophyseal hormones on the central nervous system].
    Benetato G
    Probl Actuels Endocrinol Nutr; 1966; 10():291-322. PubMed ID: 5920848
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of action of quipazine maleate on the central nervous system.
    Salas M; Cervantes M; Guzman-Flores C
    Bol Inst Estud Med Biol Univ Nac Auton Mex; 1966; 24(1):191-205. PubMed ID: 5299393
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo and in vitro activity of a vasoactive drug 9-(3,5-dimethylpyrazole-1-carboxamido)-7-methyl-4,6,6a,7,8,9,10,10-alpha-octahydroindolo[4,3-fg] quinoline maleate.
    Willard PW; Powell CE
    J Pharm Sci; 1968 Aug; 57(8):1390-4. PubMed ID: 5677346
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacoligical study on 2-(O-chlorophenyl)-2-methylamino-cyclohexanone HC1 (CI-581), especially the effect on the central nervous system].
    Shibuya T; Horibe M; Sasaki Y; Matsumiya T; Matsuda H
    Zasshi Tokyo Ika Daigaku; 1969; 27(2):249-56. PubMed ID: 5817870
    [No Abstract]   [Full Text] [Related]  

  • 14. [Excellence of quipazine in the characterization of serotoninergic receptors and mechanisms].
    Hong E
    Gac Med Mex; 1982 Apr; 118(4):158-64. PubMed ID: 7117731
    [No Abstract]   [Full Text] [Related]  

  • 15. [Central and peripheral effects of cholinomimetics and their dependence on lipoid solubility].
    Herz A; Holzhäuser H; Teschemacher H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966; 253(2):280-97. PubMed ID: 4222746
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological properties of indolylalkyl derivatives of quipazine].
    Trubitsyna TK; Kashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(5):530-6. PubMed ID: 7449980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the antihistamine preparation, phencarol, on the central nervous system].
    Kaminka ME; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(2):148-53. PubMed ID: 6108233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of ether inhalation on the CNS activities of cats].
    Mitani H
    Nihon Geka Hokan; 1969 Nov; 38(6):825-33. PubMed ID: 5393343
    [No Abstract]   [Full Text] [Related]  

  • 19. [Importance of the electroencephalogram for the pharmacology of the central nervous system].
    BRUCKE F
    Wien Med Wochenschr; 1958 Mar; 108(11):231-2. PubMed ID: 13558137
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons.
    Hirata K; Yamaguchi H; Takamura Y; Takagi A; Fukushima T; Iwakami N; Saitoh A; Nakagawa M; Yamada T
    J Pharmacol Exp Ther; 2005 Jul; 314(1):252-9. PubMed ID: 15798005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.